Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | -4.18% | -10.42% | +7.84% |
May. 15 | Blend Labs Insider Sold Shares Worth $1,992,950, According to a Recent SEC Filing | MT |
May. 08 | (BLND) BLEND Sees Q2 Revenue Range $37.5M - $41.5M | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- With an enterprise value anticipated at 3.76 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.84% | 694M | - | ||
+8.91% | 85.92B | B | ||
+5.14% | 77.91B | B+ | ||
-16.20% | 52.89B | B+ | ||
+26.18% | 48.28B | D+ | ||
+28.93% | 45.38B | D+ | ||
-34.05% | 40.83B | B- | ||
+66.72% | 38.78B | D+ | ||
-0.36% | 27.48B | C+ | ||
-26.47% | 21.52B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BLND Stock
- Ratings Blend Labs, Inc.